Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hans Schick is active.

Publication


Featured researches published by Hans Schick.


ACS Medicinal Chemistry Letters | 2014

Discovery of Spiro[cyclohexane-dihydropyrano[3,4-b]indole]-amines as Potent NOP and Opioid Receptor Agonists

Stefan Schunk; Klaus Linz; Sven Frormann; Claudia Hinze; Stefan Oberbörsch; Bernd Sundermann; Saskia Zemolka; Werner Englberger; Tieno Germann; Thomas Christoph; Babette-Y. Kögel; Wolfgang Schröder; Stephanie Harlfinger; Derek Saunders; Achim Kless; Hans Schick; Helmut Dr. Sonnenschein

We report the discovery of spiro[cyclohexane-pyrano[3,4-b]indole]-amines, as functional nociceptin/orphanin FQ peptide (NOP) and opioid receptor agonists with strong efficacy in preclinical models of acute and neuropathic pain. Utilizing 4-(dimethylamino)-4-phenylcyclo-hexanone 1 and tryptophol in an oxa-Pictet-Spengler reaction led to the formation of spiroether 2, representing a novel NOP and opioid peptide receptor agonistic chemotype. This finding initially stems from the systematic derivatization of 1, which resulted in alcohols 3-5, ethers 6 and 7, amines 8-10, 22-24, and 26-28, amides 11 and 25, and urea 12, many with low nanomolar binding affinities at the NOP and mu opioid peptide (MOP) receptors.


Archive | 2003

SPIROCYCLIC CYCLOHEXANE DERIVATIVES

Claudia Hinze; Otto Aulenbacher; Bernd Sundermann; Stefan Oberbörsch; Elmar Friderichs; Werner Englberger; Babette-Yvonne Kögel; Klaus Linz; Hans Schick; Helmut Dr. Sonnenschein; Birgitta Henkel; Valerie Sarah Rose; Michael Jonathan Lipkin


Archive | 2004

Spirocyclic cyclohexane derivatives with affinity for the orl1-receptor

Claudia Hinze; Bernd Sundermann; Hans Schick; Birgitta Henkel; Werner Englberger; Stefan Oberbörsch; Elmar Friderichs; Sven Frormann; Babette-Yvonne Kögel; Klaus Linz; Beatrix Merla; Derek Saunders; Wolfgang Schröder; Helmut Dr. Sonnenschein


ACS Medicinal Chemistry Letters | 2014

Discovery of a Potent Analgesic NOP and Opioid Receptor Agonist: Cebranopadol

Stefan Schunk; Klaus Linz; Claudia Hinze; Sven Frormann; Stefan Oberbörsch; Bernd Sundermann; Saskia Zemolka; Werner Englberger; Tieno Germann; Thomas Christoph; Babette-Y. Kögel; Wolfgang Schröder; Stephanie Harlfinger; Derek Saunders; Achim Kless; Hans Schick; Helmut Dr. Sonnenschein


Archive | 2003

4-aminomethyl-1-aryl-cyclohexylamine derivatives

Bernd Sundermann; Hans Schick; Claudia Hinze


Archive | 2009

Substituted spirocyclic cyclohexane derivatives

Saskia Zemolka; Bert Nolte; Sven Frormann; Claudia Hinze; Klaus Linz; Wolfgang Schröder; Werner Englberger; Hans Schick; Helmut Dr. Sonnenschein


Archive | 2009

Substituted 4-aminocyclohexane derivatives

Bert Nolte; Wolfgang Schröder; Klaus Linz; Werner Englberger; Hans Schick; Heinz Graubaum; Birgit Roloff; Sigrid Ozegowski; József Bálint; Helmut Dr. Sonnenschein


Archive | 2006

Pentafluorosulphanyl-substituted compound and its use for producing medicaments

Robert Frank; Bernd Sundermann; Hans Schick


Archive | 2006

Substituted spiro compounds and their use for producing pain-relief drugs

Hans Schick; Robert Frank; Melanie Reich; Ruth Jostock; Gregor Bahrenberg; Fritz Theil; Birgitta Henkel


Archive | 2006

Salts of Substituted Allophanates and Their Use in Drugs

Robert Frank; Ruth Jostock; Hans Schick; Fritz Theil; Olga Gröger; Rene Kudick; Helmut Dr. Sonnenschein; Birgitta Henkel

Collaboration


Dive into the Hans Schick's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge